This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
When it comes to the COVID-19 pandemic and health IT, if there's just one thing that everyone can agree on, it's that telehealth has gone mainstream. These factors shot telehealth and related technologies and services like connected health and remote patient monitoring through the stratosphere. Moore is all for telemedicine.
minimum investment round includes an institutional investor, company management, and Ian Mattioli’s £500K investment. Kanabo’s NHS-approved online telehealth platform, The GP Service, provides patients with video consultations, online prescriptions, and primary care services.
While telehealth boomed during the pandemic, there's a shift towards hybrid models that seamlessly blend virtual consultations with in-person care when needed. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Hybrid care is king: Patients are demanding flexibility.
Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Diabetes management: DTx products can assist in blood glucose control, insulin therapy management, and lifestyle modification for diabetes patients.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content